3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Recurrence
1
Non-Small Cell Lung Cancer ALK-positive
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Hereditary Sensory and Autonomic Neuropathies
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
ponatinib
4
Methotrexate
4
Cytarabine
4
Cyclophosphamide
4
merphos
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
venetoclax
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cladribine
2
Busulfan
2
prednylidene
1
nilotinib
1
midostaurin
1
gilteritinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
blinatumomab
1
auricularum
1
asciminib
1
Vincristine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
lorlatinib
×
90 days
×
Clear all
No trials found.